COAGULATION DISORDERS

We provide targeted DNA sequencing allowing us to focus specific areas of interest at a reduced price and faster delivery time. Our laboratory’s technology can accommodate small blood sample sizes, making it viable alternative to a trip to the phlebotomist and reducing the impact of blood-drawing on patients’ health.

COAGULATION

Genetic Testing - Coagulation Disorders

NEXT GENERATION SEQUENCING – GERMLINE MUTATION

Our Coagulation Amplicon Sequencing Panel targets the inherited causes of blood clots by sequencing 55 genes previously linked to coagulation. This assay is performed using genomic DNA isolated from human peripheral whole blood specimens.
The test is intended to identify the variants that are associated with coagulation disorders. It is performed as a pre-symptomatic genetic test in order to determine whether persons with a family history of coagulation disorders, but no current symptoms, have gene alterations associated with the disease. The test can also be used for post-symptomatic genetic testing to confirm variants of association to coagulation disorders.

ANO6
AP3B1
BHMT
BLOC1S3
CBS
DTNBP1
F10
F11
F12
F2
F5
F7
F8
F9
FGA
FGB
FGG
GP1BA
GP1BB
GP6
GP9
GpIa
GpIIa
HCII
HPS1
HPS3
HPS4
HPS5
HPS6
HRG
ITGA2
ITGA2B
ITGB1
ITGB3
LMAN1
MCFD2
MTHFR
MTR
P2RY12
PAI
PLG
PROC
PROCR
PROS1
SERPINC1
SERPINE1
SERPINF2
TBXA2R
TFPITHBD
TNF
tPA
VWF

All tests are performed in Ayass BioScience, LLC. Ayass BioScience, LLC (DBA Ayass Lung Clinic, PLLC) is a CLIA certified laboratory. If you have any questions about Genetic Testing Next Generation Sequencing at Ayass BioScience, LLC, please call today at 972-668-6005 or fill out our contact form on the bottom of this page. We will answer any question you might have.